Characteristics | Incident Malignancy, n = 880 |
---|---|
Sex, n | 878 |
Female | 592 (67.4) |
Age, n | 878 |
Mean (SD), median (IQR) | 66.6 (10.5), 67 (59–74) |
Duration of RA, n | 878 |
Mean (SD), median (IQR) | 14.1 (10.7), 11 (6–20) |
Race, n | 864 |
White | 792 (91.7) |
African American | 47 (5.4) |
Asian | 9 (1) |
Other | 16 (1.9) |
Education, n | 844 |
College or above | 471 (55.8) |
Smoking status, n | 878 |
Never smoker | 395 (45) |
Previous smoker | 349 (39.7) |
Current smoker | 134 (15.3) |
Weight, lbs, n | 880 |
Mean (SD), median (IQR) | 172.7 (41.4), 170 (145–195) |
BMI, n | 877 |
Underweight | 21 (2.4) |
Normal weight | 268 (30.6) |
Overweight | 312 (35.6) |
Obese | 276 (31.5) |
Work status, n | 859 |
Full-time | 174 (20.3) |
Part-time | 64 (7.5) |
At home | 73 (8.5) |
Student | 9 (1) |
Disabled | 111 (12.9) |
Retired | 428 (49.8) |
Insurance, n | 862 |
None | 3 (0.3) |
Private | 581 (67.4) |
Medicaid | 43 (5) |
Medicare | 464 (53.8) |
RF/CCP status, n | 602 |
Positive | 468 (77.7) |
Comorbid conditions, n | 880 |
History of CVD | 68 (7.7) |
History of serious infection | 75 (8.5) |
Solid cancer type, n | 880 |
Breast cancer | 190 (21.6) |
Lung cancer | 78 (8.9) |
Melanoma skin cancer | 83 (9.4) |
Prostate cancer | 61 (6.9) |
Uterus and ovary cancer | 36 (4.1) |
Colon cancer | 33 (3.8) |
Bladder cancer | 20 (2.3) |
Thyroid cancer | 17 (1.9) |
Other cancer | 362 (41.1) |
CDAI, n | 858 |
Mean (SD), median (IQR) | 11.2 (12.1), 8 (3–16) |
CDAI categories, n | 858 |
Remission | 218 (25.4) |
Low | 311 (36.2) |
Moderate | 197 (23.0) |
High | 132 (15.4) |
Period of cancer diagnosis, n | 880 |
2002–2006 | 124 (14.1) |
2007–2012 | 491 (55.8) |
2013–2016 | 265 (30.1) |
Values are n (%) unless otherwise specified.
↵* The index date is the first Corrona visit following a malignancy diagnosis, or the enrollment visit for those with a history of malignancy prior to enrollment. Variable reported at index date, unless otherwise noted. IQR: interquartile range; BMI: body mass index; RF: rheumatoid factor; CCP: cyclic citrullinated peptide; CVD: cardiovascular disease; CDAI: Clinical Disease Activity Index; RA: rheumatoid arthritis.